Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
life sciences
4
×
national blog main
boston blog main
boston top stories
clinical trials
national top stories
new york blog main
biotech
deals
drugs
new york
new york top stories
san diego blog main
san diego top stories
san francisco blog main
startups
achaogen
adams street partners
akcea therapeutics
alnylam pharmaceuticals
amgen
antibiotics
anylam pharmaceuticals
beijing
beta lactamase inhibitor
biomedical advanced research and development authority (barda)
brii bio
brii biosciences
cardiomyopathy
china
cholesterol
data
drug resistance
fda
glaxosmithkline
gsk
hatteras venture partners
hepatitis b
inclisiran
inotersen
What
drug
medicines
4
×
year
4
×
disease
infectious
aces
adds
ago
akcea
alliance
alnylam
amyloidosis
announced
approved
areas
attr
available
bacteria
battle
big
biopharma
biosciences
bio’s
brii
business
ceo
cholesterol
company
debilitating
earlier
exited
fda
fighting
flexible
genetic
hepatitis
inclisiran
infections
key
launched
Language
unset
Current search:
medicines
×
year
×
" life sciences "
×
@xconomy.com
4 years ago
As Cholesterol Drug Aces Big Test, MedCo CEO Open to Flexible Pricing
@xconomy.com
5 years ago
FDA OKs Pfizer Rare Disease Drug, Sets Up Battle With Alnylam, Akcea
@xconomy.com
5 years ago
Brii Bio’s Alliance with VBI Vaccines Adds Hepatitis B Drug to Pipeline
@xconomy.com
5 years ago
Qpex Biopharma Launches with $33M to Tackle Drug-Resistant Infections